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1. Introduction  
1.1 Peripheral arterial disease 
Peripheral arterial disease (PAD) is a manifestation of atherosclerosis which produces 
stenoses and occlusions in lower limbs arteries. PAD was commonly divided in four stages, 
introduced by Rene Fontaine in 1954 (Fontaine et al., 1954): stage 1 defined an asymptomatic 
patient, stage 2 defined a patient presenting with a significant impairment of his ability to 
walk (intermittent claudication). Then claudication worsens and the patient develops rest 
pain in stage 3, and non-healing ulcers or gangrene in stage 4.   
Recently, other criteria have been proposed for the diagnosis of PAD. Stage 2 of Leriche is 
now called « functional ischemia », and stages 3 and 4 are now called « critical ischemia » 
(Norgren et al., 2007). Critical ischemia is called this way because of its poor prognosis. 
With this new classification, the diagnosis of critical limb ischemia requires both clinical 
criteria, but also hemodynamic criteria (ankle-brachial index, toe pressure). Normal 
values of ankle-brachial index are between 0,9 and 1,3. PAD is characterized by ankle-
brachial values under 0,9 (0,4-0,9: functional ischemia, <0,4: critical ischemia). The normal 
value of the toe pressure is 60-65 mm Hg, it can be normal or within the limits of the 
normal in functional ischemia, but it is commonly under 10 mm Hg in critical ischemia. 
These hemodynamic criteria objectify the arterial etiology of the lesions, because it is 
sometimes difficult to define the exact origin of rest pain or tissue loss (diabetes, venous 
insufficiency…). 
Insufficient oxygen supply secondary to reduced blood flow is presumed to be the main 
physiologic cause for the manifestations of peripheral arterial disease, but more recently the 
presence of mitochondriopathy in chronically ischemic skeletal muscle has been proposed. 
Suboptimal energy production from defective mitochondria participates in PAD 
pathogenesis in addition to reduced oxygen supply (Marbini et al., 1986; Lundgren et al., 
1989; Bhat et al., 1999; Brass et al., 2001; Pipinos et al., 2008a)(Figure 1). 
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Fig. 1. Pathogenesis of peripheral arterial disease 
1.2 Mitochondrial function and oxidative stress 
Every action requires energy, and this energy is stored in adenosine triphosphate (ATP) 
molecules that are produced in the mitochondria by the process of oxidative 
phosphorylation. Mitochondria are present in every cell, but there are in high concentrations 
in muscle cells because high energetic requirements of muscles.  
1.2.1 Structure of mitochondria  
Mitochondria are enclosed within two membranes: the outer membrane and the inner 
membrane. The outer membrane is a relatively simple phospholipid bilayer, containing 
protein structures called porins which allow molecules of 10 kilodaltons in weight to pass 
through it. This explains why the outer membrane is completely permeable to nutrient 
molecules, ions, ATP and ADP molecules. The inner membrane is more complex in 
structure than the outer membrane because it contains electron transport chain, ATP 
synthetase, and transport proteins. It is freely permeable only to oxygen, carbon dioxide and 
water. The wrinkles, or folds, are organized into layers called cristae, which increase total 
surface area of the inner membrane (figure2). 
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Outer and inner membranes delineate two compartments: the intermembrane space, and the 
cytoplasmic matrix. The intermembrane space is located between the inner and the outer 
membranes. It has an important role in oxidative phosphorylation. The cytoplasmic matrix 
contains the enzymes that are responsible for citric acid cycle reactions. The matrix also 
contains dissolved oxygen, water, and carbon dioxide.  
 
Fig. 2. Mitochondrial structure.  (source: Pearson education, Inc., publishing as Benjamin 
Cummings).  
1.2.2 Functions of mitochondria 
One of the major mitochondrial functions is cellular respiration. It is a chemical process of 
releasing energy stored in glucose. The energy utilized in breaking down glucose is 
supplied by ATP molecules, and ATP molecules are produced by mitochondria. The entire 
process of aerobic cellular respiration is a three step process: 
- Glycolysis: Glucose is a six carbon sugar. The enzymes in the cytoplasmic matrix 
initiate glycolysis in which a glucose molecule is oxidized to two molecules of three 
carbon sugars. Products of glycolysis are two molecules of ATP, two molecules of 
pyruvic acid and two NADH (Nicotinamide Adenine Dinucleotide) molecules (which 
are electron carrying molecules) 
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- Citric Acid Cycle (Krebs cycle): This is the second phase of cellular respiration. The 
three carbon molecules which have been produced as a result of glycolysis are 
converted into acetyl compounds. However, the intermediary reactions of this process 
yield ATP molecules of energy, NAD and FAD molecules too. NAD and FAD 
molecules are further reduced in the Citric Acid Cycle to high energy electrons 
- Electron Transport: The electron transport chain is constituted of a series of electron 
carriers generated in the membrane of the mitochondria from Citric Acid Cycle. The 
ATP molecules are further produced by the chemical reactions of these electron carrier 
molecules. A eukaryotic cell produces about 36 ATP molecules after cellular respiration. 
In fact, mitochondrial function in cellular energy metabolism is concerned with the 
processes of fatty acid and pyruvate oxidation, resulting in the formation of acetyl-CoA, 
which is subsequently oxidized in the Citric Acid Cycle. When combined, these processes 
generate reduced coenzymes, which deliver electrons to oxygen to form water, through the 
respiratory chain of the inner membrane. The whole process of fat and carbohydrate 
oxidation is strongly exergonic and the normal mitochondrion conserves the major part of 
this energy in the form of ADP phosphorylation to ATP. This dependence on oxygen is 
critical in skeletal muscle. Under normal circumstances, skeletal muscle has the capacity to 
increase its energy turnover, and this makes the transition from rest to exercise. Efficient 
oxygen delivery is very important for normal mitochondrial function, and patients suffering 
from peripheral arterial disease have a decreased blood flow to the legs due to 
arteriosclerosis, making less oxygen available to the mitochondria. 
Other main mitochondrial functions are control of cell cycle, management of apoptosis, 
monitoring of cell differentiation, growth and development and reactive oxygen species 
production and clearance. 
1.2.3 Mitochondria and reactive oxygen species  
Mitochondria, main energy sources of the cells, are causes and targets of increased oxidative 
stress. Thus, the role of mitochondria extends far beyond energy production, as they are 
important generators of reactive oxygen species (ROS), which can act either as second 
messengers or as a source of cellular damage, depending on the produced amount. ROS are 
a double-edged sword: they are beneficial by playing an important role in cell signaling 
involved in antioxidant defense network, but could be harmful by inducing excessive 
oxidative stress resulting in protein carboxylation, lipids peroxydation and DNA damage. 
These free radicals have oxidizing properties, and they react in the environment where they 
are produced with a variety of biological substrates: fats, carbohydrates, proteins and DNA. 
There are also environmental factors that generate free radicals: pollution, sun exposure, 
smoking, consumption of alcohol or drugs, physical exercise. These situations induce an 
overproduction of reactive oxygen species. There are also defense systems that can regulate 
the production of theses species: free radicals are neutralized by enzymatic systems 
(superoxide dismutase, catalase and glutathione peroxidase), elements (copper, zinc, iron, 
selenium), as well as antioxidants such as vitamins A, C and E (Figure 3).  
ROS include radical species such as primary superoxide O2−, and its conjugated acid 
hydroperoxyl radical HO2. Also included are the hydroxyl (OH), carbonate (CO3 −), 
peroxyl (RO2), and alkoxyl (RO) radical. Also some non-radical species are ascribed to  
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Fig. 3. Reactive oxygen species in peripheral arterial disease. SOD: superoxide dismutase; 
GPX: gluthatione peroxidase 
ROS, namely H2O2, HOCl, fatty acid hydroperoxides (FAOOH), reactive aldehydes, singlet 
oxygen and other compounds (Chance et al., 1979). Superoxide anion O2− is the most 
important, it is a fairly stable compound, especially in an aqueous environment at neutral 
pH. Its toxicity is principally based on generation of further reactive species, called 
“downstream products” of O2 −, which are then able to attack intracellular biomolecules.  
There are currently seven separate sites of mitochondrial ROS production that have been 
identified (Figure 4) (Brand et al., 2004).  
 
Fig. 4. Sites and topology of mitochondrial superoxide production. PDH: pyruvate 
dehydrogenase ; OGDH: 2-oxoglutarate dehydrogenase ; Site IF: NADH binding site of 
complex I ; Site IQ: uniquinine reduction site of complex I  
ETFQOR: electron transferring flavoprotein ubiquinone oxidoreductase ; GPDH: glycerol 3-
phosphate dehydrogenase  
Site IIIQO: quinone binding site of the Q-cycle in complex III. 
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The relative importance of each site to total superoxide production in isolated mitochondria 
is contentious, partly because of different assays, different substrates and different sources 
of mitochondria. Most assays of superoxide production from defined sites measure maximal 
capacities for superoxide production, and the actual rate from each site in the absence of 
inhibitors is not known. During reverse electron transport from succinate to NAD+, 
complex I can produce superoxide at high rates (Han et al., 2001; Votyakova & Reynolds, 
2001; Kushnareva et al., 2002; Liu et al., 2002; Han et al., 2003; Turrens, 2003; Lambert & 
Brand, 2004), although the physiological relevance is unclear (Votyakova & Reynolds, 2001). 
During forward electron transport from NAD-linked substrates (which may be more 
physiological), most mitochondria produce superoxide at high rates after addition of 
inhibitors such as rotenone (for complex I) (Han et al., 2001; Liu et al., 2002; St-Pierre et al., 
2002; Han et al., 2003; Lambert & Brand, 2004) or antimycin A (for complex III)(Liu et al., 
2002; St-Pierre et al., 2002; Muller et al., 2004). Other physiologically relevant substrates, such 
as fatty acids and glycerol 3-phosphate, may cause superoxide production from sites that are 
less active during pyruvate oxidation, such as ETF-Q oxidoreductase and glycerol 3-
phosphate dehydrogenase. 
O2− in the matrix is converted to H2O2 by matrix MnSOD, while O2− released to the 
intramembrane space is partly dismuted by intermembrane space CuZnSOD (Inoue et al., 
2003). Any residual O2− which diffuses into the cytosol is similarly converted by the 
cytosolic CuZnSOD. If any mitochondrial O2− can reach the extracellular space, it is then 
detoxified by extracellular CuZnSOD (SOD3) (Brand, 2010). Non-enzymatic 
lipoperoxidation is also a detoxification reaction. It can be considered not only as a 
detoxification reaction, but, due to its self-propagating nature, also as a new radical source 
initiated by the highly reactive radicals. Glutathione-based systems, including glutathione S 
transferase and the thioredoxin system, including peroxiredoxins, constitute the major redox 
buffer in the cytosol. Other detoxification systems (degrading H2O2 and ROS) are proteins of 
thioredoxin family, acting in concert with the thioredoxin-dependent peroxide reductase, 
and a family glutathione-S- transferase. H2O2 can be reduced to water by catalase or 
glutathione peroxidase, or alternatively to the hydroxyl radical in the presence of reduced 
copper or iron (Camello-Almaraz et al., 2006).  
Increased oxidative stress plays a key role in PAD and IR-induced muscular impairments. 
Both increased ROS secondary to mitochondrial dysfunction and decreased ROS catabolism 
are involved (Figures 1 and 3).  
2. Mitochondrial and oxidative stress analysis of muscle biopsies 
2.1 Histological methods 
2.1.1 Histological analysis of skeletal muscle mitochondria 
Mitochondria can be detected in confocal microscopy by conventional fluorescent stains, 
such as rhodamine 123 and tetramethylrosamine. These stains are readily sequestered by 
functioning mitochondria, but they are subsequently washed out of the cells once the 
mitochondrion's membrane potential is lost. This characteristic limits their use in 
experiments in which cells must be treated with aldehyde-based fixatives or other agents 
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that affect the energetic state of the mitochondria. To overcome this limitation, it is possible 
to use a serie of mitochondrion selective stains (MitoTracker probes®) that are concentrated 
by active mitochondria and well retained during cell fixation. Because these mitochondrion 
selective stains are also retained following permeabilization, the sample retains the 
fluorescent staining pattern characteristic of live cells during subsequent processing steps 
for immunocytochemistry, in situ hybridization or electron microscopy. 
MitoSOX® Red mitochondrial superoxide indicator is a fluorogenic dye for highly selective 
detection of superoxide in the mitochondria of live cells. It is live-cell permeant and is 
rapidly and selectively targeted to the mitochondria. Once in the mitochondria, it is 
oxidized by superoxide (but not by other reactive oxygen species) and exhibits red 
fluorescence. Oxidation of the probe is prevented by superoxide dismutase. The oxidation 
product becomes highly fluorescent (excitation/emission maxima of approximately 510/580 
nm) upon binding to nucleic acids. Cells adhering to coverslips have to be covered by 1 or 2 
mL of 5 M of MitoSOX® reagent working solution, and incubated for 10 minutes at 37°C, 
protected from light. They are then washed gently three times with warm buffer, and 
mounted in warm buffer for confocal microscopy imaging (Mukhopadhyay et al., 2007) 
(figure 5). 
 
 
 
Merge 
 
 
MitoTracker 
 
MitoSOX 
 
Fig. 5 Assessment of superoxide generation. MitoSOX Red stain (top panel) revealed the 
presence of superoxide anion MitoSOX Red colocalized with MitoTracker Green (middle 
panel) in merged images (bottom panels), indicating that the excess superoxide anion was 
concentrated in mitochondria (Quinzii et al., 2008).  
In transmission electron microscopy, mitochondrial ultrastructure can be studied. The 
material is fixed, embedded, sectioned, and then examined. It is important to note that the 
sections must be less than 0.1 m in thickness, even less than 0.05 m, in order to show the 
structural details described with enough clarity for profitable study of the mitochondria 
(Frey et al., 2002) (figure 6).  
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Fig. 6. Micrographs of transmission electron microscopy sections of mitochondria, TEM 
×60K. The left photo represent a healthy mitochondrion the arrow indicates the cristae; the 
right photo represents a swelling mitochondrion (Li et al., 2010).  
2.1.2 Microscopy fluorescence: Dihydroethidium staining 
To detect the presence of ROS in skeletal muscles, serial sections (10 μm-thick) are cut on a 
cryostat microtome, mounted into glass slides and incubated with 2.5 μM dihydroethidium 
(DHE). DHE produces red fluorescence when oxidized to ethidium bromide (EtBr), mainly 
by superoxide anion. After staining, sections are examined under an epifluorescence 
microscope (Nikon Eclipse E800) and emission signal are recorded with a Zeiss filter 
(Dikalov et al., 2007) (figure 7). 
 
Fig. 7. A representative photo of Superoxide production by dihydroethidium staining of 
tissue in the acute phase of stress cardiomyopathy (Nef et al., 2008) 
Inhibitors of NADPH oxidase (diphenylene iodonium) and xanthine oxidase are known to 
reduce mitochondrial superoxide production through inhibiting NADH ubiquinone 
oxidoreductase (complex I) (Riganti et al., 2004).  
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2.2 Functional methods 
2.2.1 Mitochondrial respiratory chain complexes activities using saponin skinned 
fibres 
The mitochondrial respiratory chain complexes activities study is described in an other 
chapter. This technique is based on the measure of oxygen consumption in skinned fibres in 
order to determine the functional oxidative capacity of the skeletal muscle in its cellular 
environment (Veksler et al., 1987; Riganti et al., 2004) (see the chapter from Charles et al. for 
much more explanations and the description of the methods).  
2.2.2 H2O2 Production in permeabilized fibres 
H2O2 production is assessed in permeabilized fibres (Kuznetsov et al., 2008) in response to 
sequential addition of substrates and inhibitors (Anderson & Neufer, 2006). H2O2 
production is measured with Amplex Red reagent (Invitrogen), which reacts with H2O2 in a 
1:1 stoichiometry catalyzed by HRP (Horse Radish Peroxidase; Fluka Biochemika) to yield 
the fluorescent compound resorufin and molar equivalent O2. Resorufin has 
excitation/emission characteristics of 563/587 nm and is extremely stable once formed. 
Fluorescence is measured continuously [change in fluorescence (ΔF)/sec] with a 
spectrofluorometer with temperature control and magnetic stirring. After a baseline, ΔF 
(reactants only) is established; the reaction is initiated by addition of a permeabilized fibre 
bundle to 600 µl of buffer Z with glutamate (5µM) and malate (2.5µM) as substrates for 
complex I and succinate (5mM) for complex II. ADP (2mM) is injected in the reaction buffer 
and led to a reduction in H2O2 release, which is expected when electron flow through the 
respiratory chain is stimulated. Finally, addition of the complex I inhibitor amytal (2mM) 
and the complex III inhibitor antimycin (8µM) led to interruption of normal electron flow 
and induced an increase in H2O2 release. 
3. Mitochondrial dysfunctions during peripheral arterial disease 
During PAD, significant muscles ischemia/reperfusion is well known to induce skeletal 
muscles alterations (Figure 1). The pathogenesis of PAD manifestations is lead to the 
development of athero-occlusive disease in the lower limb arteries. Arterial stenoses usually 
do not affect the blood supply at rest, but at the time of walking or other exercise, they make 
the leg ischemic and painful forcing the patient to rest. At rest, perfusion returns again to 
normal levels. These cycles of ischemia and reperfusion launch a cascade of inflammatory 
changes and induce the production of ROS in the skeletal muscle. Multiple daily 
ischemia/reperfusion events initiated by simple activities such as walking result, over time, 
in morphological and ultrastructural changes in both the contractile element of the muscle 
and its mitochondria. Dysfunctional mitochondria then further lower the already decreased 
(by compromised blood supply) energy levels in the pathologic muscle and become sources 
of ever increasing levels of ROS and possibly inducers of apoptosis. A vicious cycle is thus 
initiated gradually leading to deteriorating mitochondrial function and escalating ROS 
production with ongoing damage of every structure in the myocytes. Apoptosis, along with 
cellular necrosis (from ischemia, reactive oxygen species, and low energy levels), may then 
be induced, eventually leading to a severe myopathy that significantly affects the function 
and performance of PAD limbs. In addition, nerves, skin, and subcutaneous tissues 
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damages are formed, ultimately leading to the characteristically atrophic legs of patients 
with advanced PAD having thin muscles; brittle, hairless, and thin skin with shiny texture; 
and impaired sensorimotor function. On the basis of these concepts, it is easy to understand 
how claudication, rest pain, and tissue loss find their place in the heart of this continuum of 
events, coming into view as the external manifestations of ongoing tissue injury and 
deterioration (Blaisdell, 2002; Pipinos et al., 2008a). 
3.1 Selected experimental data (Table 1) 
Author Journal Year Histology 
Oxidative 
stress 
Respirometry 
Makris Vascular 2007 
Myopathic 
features 
Drop in total 
protein content
Increased 
mitochondrial 
content 
Increased 
oxidative stress
Bioenergetic 
decline 
 
Inadequate 
oxidative 
phosphorylation 
 
Decreased ATP 
energy production 
Pipinos II J Vasc Surg 2000 
Myopathic 
features 
 
Increased 
mitochondrial 
content, more 
oxidative type 
fibres. 
- Increased 
oxidative 
stress : 
xanthine 
oxidase and 
activated 
neutrophils are 
source of ROS 
- Alteration of 
activity and 
expression of 
MnSOD. 
- Damage to 
mtDNA 
Decreased 
activities of 
complexes I, III, 
and IV. 
Pipinos II 
 
 
Vasc 
Endovasc 
Surg 
 
 
2008b 
Brass Vasc Med 
1996 
2000 
Wallace Am Heart J 2000 
Increased 
mitochondrial 
content 
Increased 
oxidative stress
- 
Levak-Frank 
J Clin 
Invest 
1996 
Increased 
mitochondrial 
content 
- - 
Wredenberg 
Proc Nath 
Acad Sci 
USA 
1999 
Table 1. Experimental data  
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Peripheral arterial disease is a consequence of compromised blood supply to the ischemic 
limb (Brass, 1996; Brass & Hiatt, 2000). Experimental data show that skeletal muscle 
responds to inflow arterial occlusion with the development of myopathic histological 
changes, a drop in total protein content, and a trend toward decreased wet weight (Makris, 
et al., 2007 ; Pipinos, et al., 2008b). Peripheral arterial disease is characterized by a significant 
increase in the mitochondrial content of skeletal muscle, and mitochondrial proliferation is 
characteristic of mitochondrial diseases and aging (Levak-Frank et al., 1995; Wallace, 2000; 
Wredenberg et al., 2002; Makris et al., 2007; Pipinos et al., 2008b). In skeletal muscle, an 
upregulation of mitochondrial biogenesis may be associated with and alteration of muscle 
fibre type toward the more oxidative type I and IIa fibres (Pipinos et al., 2008b).  
Defective mitochondria are central to this myopathy, through compromised performance as 
primary energy producers and regulators of oxygen radical species. Thus, PAD myopathy is 
characterized by an increased content of dysfunctional mitochondria having significant 
defects in electron transport chain complexes I, III, and IV (Pipinos et al., 2000; Pipinos et al., 
2008b). These defects are associated with a bioenergetic decline, characterized by inadequate 
oxidative phosphorylation, decreased ATP energy production, and increased oxidative 
stress (Makris et al., 2007; Pipinos et al., 2008b). Ischemic skeletal muscle sustains substantial 
oxidative injuries indicated by an increase in protein carbonylation and lipid peroxidation 
adducts. Under resting conditions, a large proportion of cellular reactive oxygen species is 
produced in the mitochondria (Wallace, 2000).  
Thus, ischemia/reperfusion is the central problem in animals with inflow arterial occlusion 
(Brevetti et al., 2001). Ischemia/reperfusion increases oxidative stress, triggers inflammation 
and oxidative damage to the tissues, and initiates mitochondrial injury and dysfunction. 
Mitochondrial dysfunction can then be perpetuated by repeated destructive cycles of 
ischemia/reperfusion, causing amplification of respiratory chain defects, compromised 
bioenergetics, increased reactive oxygen species production, diminished MnSOD 
antioxidant activity. The combination of compromised bioenergetics and worsening 
oxidative stress may then lead to progressive oxidative damage of structures in the 
myocytes (Brass, 1996; Brass & Hiatt, 2000; Makris et al., 2007; Pipinos et al., 2008a).  
There are non-invasive techniques that can evaluate in vivo the mitochondrial energy 
transformation by the monitoring of the tissue oxygen level: either directly with the 
31phosphorous magnetic resonance spectroscopy (Hands et al., 1990; Greiner et al., 2006), or 
indirectly with infrared spectroscopy (Hands et al., 1986; Watanabe et al., 2004; Ubbink & 
Koopman, 2006). The 31phosphorous magnetic resonance spectroscopy is used to determine 
the concentrations of metabolites involved in muscle energy metabolism (phosphocreatin, 
inorganic phosphate, and ATP). From these data, free ADP and pH may be calculated 
(Quistorff et al., 1993). The infrared spectroscopy is used to measure the state of oxygen 
saturation in hemoglobin and myoglobin in blood and muscle at a given time and a given 
location. It can be considered as an indirect measure of the muscle perfusion versus oxygen 
consumption (Comerota et al., 2003).   
Mitochondrial function may also be evaluated by respirometry on muscle biopsies. The 
feasibility, indications, contra-indications are now well known and such a technique become 
usual in specialized centers. Thus, skeletal muscle biopsies can be obtained during surgery, 
or they can be obtained under local anesthesia. Biopsy sites can be anesthetized with a 2% 
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lidocaine solution, and 1.0 cm incisions can be made through the skin and gastrocnemius 
fascia. A modified 5 mm Bergstrom biopsy needle can then be inserted 10-15 mm and used 
to obtain 40 to 50 mg of skeletal muscle. Contraindications are essentially represented by 
bleeding disorders, infection at biopsy sites, or allergy to local anesthetics.  
3.2 Selected clinical data (Table 2) 
Author Journal Year Histology Oxidative stress Respirometry 
Makris Vascular 2007 
Myopathic 
features 
 
Increased 
mitochondrial 
content 
 
More type I 
fibres 
Increased 
oxidative stress 
Bioenergetic 
decline 
Pipinos 
II 
J Vasc Surg 2000 
Increased 
oxidative stress : 
xanthine oxidase 
and activated 
neutrophils are 
source of ROS 
 
Alteration of 
activity and 
expression of 
MnSOD 
 
Damage to 
mtDNA 
Decreased 
activities of 
complexes I, 
III, and IV. 
Pipinos 
II 
 
 
Vasc 
Endovasc 
Surg 
 
2008 
Brass Vasc Med 2000 
Increased 
oxidative stress 
Table 2. Clinical data.  
Previous studies have shown that PAD is associated with alterations in skeletal muscle 
histology (Brass & Hiatt, 2000; Makris et al., 2007; Pipinos et al., 2008b). Necrotic and 
regenerating fibres as well as inflammation have been seen in the diseased legs in 
comparison to contralateral legs of patients with unilateral peripheral arterial disease 
hospitalized for surgical evaluation. Furthermore, in the setting of aortic aneurysm repair in 
human, light microscopy revealed a consistent granulocyte infiltration in the ischemic and 
reperfused skeletal muscle. Ultrastructural damage to the muscle fibers was seen during 
ischemia and became more severe upon reperfusion. The recruitment of granulocytes into 
the muscle tissue paralleled the activation of the blood complement system and an increase 
in circulating neutrophils (Formigli L et al., 1992). 
3.2.1 Patients with functional ischemia 
The 31phosphorous magnetic resonance spectroscopy examination shows a higher inorganic 
phosphate/phosphocreatin ratio compared to control patients (Hands et al., 1986; Zatina et 
al., 1986; Hands et al., 1990). The infrared spectroscopy examination shows a large drop in 
www.intechopen.com
Skeletal Muscle Mitochondrial Function 
in Peripheral Arterial Disease: Usefulness of Muscle Biopsy 145 
the oxygen saturation in the muscle and an increased oxygenation recovery time after 
exercise when compared to control patients (Kemp et al., 2001; Comerota et al., 2003).  
Histological examination shows more type I muscle fibres containing a high amount of 
mitochondria in the gastrocnemius muscle of patients with functional ischemia. In addition, 
the severity of the peripheral arterial disease was correlated with the increased percentage 
of type I fibres (Makitie & Teravainen, 1977). 
3.2.2 Patients with critical limb ischemia 
The 31phosphorous magnetic resonance spectroscopy examination shows a higher 
intracellular pH, and a higher inorganic phosphate/phosphocreatin ratio compared to 
control patients (Hands et al., 1986; Zatina et al., 1986; Hands et al., 1990). The infrared 
spectroscopy examination shows a large decrease in the oxygen saturation in the muscle and 
an increased oxygenation recovery after surgery. Respirometry shows a reduced 
mitochondrial respiratory rate in the gastrocnemius muscle compared to control patients 
(Pipinos et al., 2003; Pipinos et al., 2006). The reduced respiratory rate is specifically located 
to complexes I, III and IV enzymes of the respiratory chain; probably due to reactive oxygen 
species generated damage (Sjostrom et al., 1980; Pipinos et al., 2003). 
4. Improving mitochondrial function and reducing oxidative stress: selected 
experimental and clinical results (Table 3) 
 
Author Journal Year Type Histology 
Oxidative 
stress 
Respiro-
metry 
Necrosis 
Tran 
Eur J 
Pharmacol
2011 Pre - 
Decreased 
superoxide 
production 
 
C I, III and IV 
activities 
normalized Reduced 
infarct 
size 
Andreadou
Mini Rev 
Med Chem
2008a,b
Pre
Post
 
- - - 
Martou 
J Appli 
Physiol 
2006 Pre
Normal 
morphology 
 
- - - 
Addison 
Am J 
Physiol 
Heart Circ 
Physiol 
2003 Pre
Attenuation of 
neutrophil 
accumulation
Decreased 
oxidative 
stress 
No 
bioenergetic 
decline 
- 
Thaveau J Vasc Surg 2007 Pre - - 
Restoration of 
complexes I 
and II 
activities 
- 
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Okorie 
Eur  
Heart J 
2011 Post
- 
Decreased 
oxidative 
stress by 
inihibition of 
the opening of 
mPTP 
- - 
McAllister 
Am J 
Physiol 
Regul Integr 
Comp 
Physiol 
2008 Post
Eberlin 
Plast 
Reconstr 
Surg 
2009 Post
Decreased of 
injured fibres
- - 
Reduced 
infarct 
size 
 
Charles Br J Surg 2011 Post - 
Decreased 
oxidative 
stress 
Preserved 
antioxydant 
defense 
 
Increased 
complexes I, 
II, III, and IV 
activities 
- 
Tsubota 
Eur J Vasc 
Endovasc 
Surg 
2010 Post
Attenuation of 
neutrophil 
accumulation
- - 
Reduced 
tissue 
necrosis 
Table 3. Effects of pre- and post-conditioning. This table summarizes clinical studies realized 
on pre- or postconditioning. 
4.1 Ischemic pre- and post-conditioning 
Besides reducing preoperative ischemic time and surgery duration, ischemic 
preconditioning -defined as brief episodes of ischemia/reperfusion applied before sustained 
ischemia- decreases skeletal muscle mitochondrial dysfunction, enhances limb and remotes 
organ protections. Furthermore, remote and local ischemic preconditioning equivalently 
protects skeletal muscle mitochondrial function during experimental aortic cross-clamping 
(Mansour et al., in Press). Nevertheless, ischemia occurrence is difficult to predict and might 
limit a broader use of ischemic preconditioning. Controlled reperfusion appears thus as a 
valuable therapeutic approach after limb ischemia and ischemic post-conditioning, 
characterized by repeated cycles of IR performed at the onset of reperfusion, appeared safe 
and easy to perform.  
Ischemic preconditioning has been mainly elucidated in experimental cardiac ischemia. 
Ischemic preconditioning utilizes endogenous as well as distant mechanisms in skeletal 
muscle, liver, lung, kidney, intestine and brain in animal models to convey varying degrees 
of protection from ischemia/reperfusion injury (Ambros et al., 2007). Specifically, 
preconditioned tissues exhibit altered energy metabolism, better electrolyte homeostasis and 
genetic reorganization, as well as less oxygen-free radicals and activated neutrophils release, 
reduced apoptosis and better microcirculatory perfusion. To date, there are few human 
studies, but trials suggest that different organ in human such as heart, liver, lung and 
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skeletal muscle acquire protection after ischemia/reperfusion (Sjostrom et al., 1980; Ali et 
al.,2007; Cheung M et al., 1996; Kharbanda et al., 2002). It has been showed that ischemic 
preconditioning positively influenced muscle metabolism during reperfusion, and this, 
results in an increase in phosphocreatin production and higher oxygen consumption 
(Andreas et al., 2011). 
Experimental data showed that ischemic postconditioning confers protection against 
different organ injuries caused by longer circulatory occlusions during elective major 
vascular surgeries, because it causes a significant reduction in systemic inflammatory 
response (TNF-alpha, oxygen-derived free radicals) (Eberlin et al., 2009). Besides the heart 
(Skyschally et al.,2009), postconditioning is also effective in salvage of ischemic skeletal 
muscle from reperfusion injury and the mechanism likely involves inhibition of opening of 
the mPTP and/or reduced oxidative stress (Szijarto et al.,2009; Tsubota et al., 2010; Park et al., 
2010; Guyrkovic et al., 2011; Mc Allister et al., 2008; Charles et al., 2011). There are few human 
studies, but it has been showed that postconditioning by intermittent early reperfusion 
reduces ischemia/reperfusion injury, that might depend on K(ATP) channel activation, and 
is mimicked by inhibition of the mPTP at reperfusion (Okorie et al., 2011).  
4.2 Pharmacological protection of skeletal muscle in the setting of 
ischemia/reperfusion 
Although preconditioning is a powerful form of protection, its clinical application is limited 
because of practical reasons. In fact, the short ischemic insults in preconditioning have to be 
applied before the onset of sustained period of ischemia which cannot be precisely 
anticipated. On the contrary, the very brief insults in postconditioning have to be applied 
immediately after the end of the long ischemia thus making the intervention more easily 
applicable. Both mechanisms limit the reperfusion injury but easier approaches deserve to 
be studied. 
Pharmacological preconditioning and postconditioning represent ideal alternatives that may 
substitute the short ischemic insults for pharmaceuticals means. The components of 
preconditioning share two main pathways, one that involves the mitochondrial K(ATP) 
channels- free radicals and PKC and another one that involves adenosine and PKC. 
Reperfusion injury salvage kinases (RISK) prevent the mitochondrial permeability transition 
pores (mPTP) opening which destroy the mitochondria and cause cell death. PC via PKC 
and postconditioning via gradual restoration of pH at reperfusion up-regulate RISK and 
preserve viable part of the ischemic region. In order to confer pharmacological protection, 
novel therapeutic strategies, based on the knowledge of the ligands, of the receptors and of 
the intracellular signaling pathways have emerged (Addison et al., 2003; Gamboa et al., 2003; 
Martou et al., 2006; Andreadou et al., 2008b). Adenosine, nicorandil, tempol, coenzyme Q 
and other agents (Addison et al., 2003; Gamboa et al., 2003; Martou et al., 2006; Thaveau et al., 
2010) have been already used as pharmacological mimetics of ischemic preconditioning. 
Furthermore, agents that increase RISK or directly prevent mPTP are also under 
investigation as postconditioning analogues (Andreadou et al., 2008a; Tsubota et al., 2010; 
Tran et al., 2011). Antioxidant systems are also important: several endogenous antioxidant 
systems are found in muscle tissue, these include alpha-tocopherol, histidine-containing 
dipeptides, and antioxidant enzymes such as glutathione peroxidase, superoxide dismutase, 
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and catalase. The contribution of alpha-tocopherol to the oxidative stability of skeletal 
muscle is largely influenced by diet. Dietary supplementation of tocopherol has been shown 
to increase muscle alpha-tocopherol concentrations and to inhibit lipid oxidation. Dietary 
selenium supplementation has also been shown to increase the oxidative stability of muscle 
presumably by increasing the activity of glutathione peroxidase, and dietary restriction 
improves systemic and muscular oxidative stress (Rodrigues et al., 2011). The oxidative 
stability of skeletal muscle is also influenced by the histidine-containing dipeptides, 
carnosine and anserine (Chan & Decker, 1994).  
5. Conclusions / Perspectives 
Mitochondria are the main energy source of the cells and mitochondrial dysfunction is 
associated with cell and organ impairment. Consistently, IR has been shown to induce 
skeletal muscle mitochondrial dysfunctions in animals and humans and improving skeletal 
muscle mitochondrial function is an interesting and clinically pertinent therapeutic goal. 
Indeed, improving skeletal muscle mitochondrial function enhances walking capacities in 
patients suffering from peripheral arterial disease.  
Muscle biopsy allows to precisely determine the deleterious effects of IR on skeletal muscle 
and can be used to better stratify patient’s risk and to guide therapy. Ischemic pre- and post-
conditioning and pharmacologic conditioning allows protection of skeletal muscle in the 
setting of ischemia/reperfusion, decreasing mitochondrial respiratory chain injury, 
reducing reactive oxygen species (ROS) production and enhancing muscles antioxidant 
defence.  
Future work will be useful to determine whether even smaller biopsies, analyzed after being 
frozen, might yield the same information. 
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